Identification of CD245 as myosin 18A, a receptor for surfactant A: A novel pathway for activating human NK lymphocytes

References

• Rosenberg EB, Herberman RB, Levine PH, Halterman RH, McCoy JL, Wunderlich JR. Lymphocyte cytotoxicity reactions to leukemia-associated antigens in identical twins. Int J Cancer 1972; 9(3):648-58; PMID:4513057; http://dx.doi.org/10.1002/ijc.2910090323
   PubMedGoogle Scholar
• Benson DM, Caligiuri MA. Killer immunoglobulin-like receptors and tumor immunity. Cancer Immunol Res 2014; 2(2):99-104; PMID:24592397; http://dx.doi.org/10.1158/2326-6066.CIR-13-0219
   PubMed Web of Science ®Google Scholar
• Moffett-King A. Natural killer cells and pregnancy. Nat Rev Immunol 2002; 2(9):656-63; PMID:12209134; http://dx.doi.org/10.1038/nri886
   PubMed Web of Science ®Google Scholar
• Lanier LL. Up on the tightrope: natural killer cell activation and inhibition. Nat Immunol 2008; 9(5):495-502; PMID:18425106; http://dx.doi.org/10.1038/ni1581
   PubMed Web of Science ®Google Scholar
• Le Bouteiller P, Barakonyi A, Giustiniani J, Lenfant F, Marie-Cardine A, Aguerre-Girr M, Rabot M, Hilgert I, Mami-Chouaib F, Tabiasco J et al. Engagement of CD160 receptor by HLA-C is a triggering mechanism used by circulating natural killer (NK) cells to mediate cytotoxicity. Proc Natl Acad Sci U S A 2002; 99(26):16963-8; PMID:12486241; http://dx.doi.org/10.1073/pnas.012681099
   PubMed Web of Science ®Google Scholar
• Bensussan A, Gluckman E, Marsafy S el, Schiavon V, Mansur IG, Dausset J, Boumsell L, Carosella E. BY55 monoclonal antibody delineates within human cord blood and bone marrow lymphocytes distinct cell subsets mediating cytotoxic activity. Proc Natl Acad Sci U S A 1994; 91(19):9136-40; PMID:8090781; http://dx.doi.org/10.1073/pnas.91.19.9136
   PubMed Web of Science ®Google Scholar
• Melero I, Johnston JV, Shufford WW, Mittler RS, Chen L. NK1.1 cells express 4-1BB (CDw137) costimulatory molecule and are required for tumor immunity elicited by anti-4-1BB monoclonal antibodies. Cell Immunol 1998; 190(2):167-72; PMID:9878117; http://dx.doi.org/10.1006/cimm.1998.1396
   PubMed Web of Science ®Google Scholar
• Lin W, Voskens CJ, Zhang X, Schindler DG, Wood A, Burch E, Wei Y, Chen L, Tian G, Tamada K et al. Fc-dependent expression of CD137 on human NK cells: insights into «agonistic» effects of anti-CD137 monoclonal antibodies. Blood 2008; 112(3):699-707; PMID:18519814; http://dx.doi.org/10.1182/blood-2007-11-122465
   PubMed Web of Science ®Google Scholar
• Kohrt HE, Colevas AD, Houot R, Weiskopf K, Goldstein MJ, Lund P, Mueller A, Sagiv-Barfi I, Marabelle A, Lira R et al. Targeting CD137 enhances the efficacy of cetuximab. J Clin Invest 2014; 124(6):2668-82; PMID:24837434; http://dx.doi.org/10.1172/JCI73014
   PubMed Web of Science ®Google Scholar
• Kohrt HE, Houot R, Weiskopf K, Goldstein MJ, Scheeren F, Czerwinski D, Colevas AD, Weng WK, Clarke MF, Carlson RW et al. Stimulation of natural killer cells with a CD137-specific antibody enhances trastuzumab efficacy in xenotransplant models of breast cancer. J Clin Invest 2012; 122(3):1066-75; PMID:22326955; http://dx.doi.org/10.1172/JCI61226
   PubMed Web of Science ®Google Scholar
• Kohrt HE, Houot R, Goldstein MJ, Weiskopf K, Alizadeh AA, Brody J, Müller A, Pachynski R, Czerwinski D, Coutre S et al. CD137 stimulation enhances the antilymphoma activity of anti-CD20 antibodies. Blood 2011; 117(8):2423-32; PMID:21193697; http://dx.doi.org/10.1182/blood-2010-08-301945
   PubMed Web of Science ®Google Scholar
• Marie-Cardine A, Boumsell L, Bensussan A. The T-cell panel DY12 and DY35 mAbs define a novel receptor associated with protein tyrosine phosphatase activity in the leukeamic cell line YT indi. In: Leucocyte Typing VII. Oxford University Press. D Mason; 2002, Oxford University press, New York, USA. Edition D Mason. p. 688.
   Google Scholar
• Giustiniani J, Marie-Cardine A, Bensussan A. A soluble form of the MHC class I-specific CD160 receptor is released from human activated NK lymphocytes and inhibits cell-mediated cytotoxicity. J Immunol 2007; 178(3):1293-300; PMID:17237375; http://dx.doi.org/10.4049/jimmunol.178.3.1293
   PubMed Web of Science ®Google Scholar
• Dufresne-Martin G, Lemay J-F, Lavigne P, Klarskov K. Peptide mass fingerprinting by matrix-assisted laser desorption ionization mass spectrometry of proteins detected by immunostaining on nitrocellulose. Proteomics 2005; 5(1):55-66; PMID:15602772; http://dx.doi.org/10.1002/pmic.200400902
   PubMed Web of Science ®Google Scholar
• Mansur I-G, Schiavon V, Giustiniani J, Bagot M, Bensussan A, Marie-Cardine A. Engagement of IL-1 receptor accessory protein (IL-1RAcP) with the monoclonal antibody AY19 provides co-activating signals and prolongs the CD2-induced proliferation of peripheral blood lymphocytes. Immunol Lett 2011; 139(1–2):52-7; PMID:21600927; http://dx.doi.org/10.1016/j.imlet.2011.04.015
   PubMed Web of Science ®Google Scholar
• Mori K, Furusawa T, Okubo T, Inoue T, Ikawa S, Yanai N, Mori KJ, Obinata M. Genome structure and differential expression of two isoforms of a novel PDZ-containing myosin (MysPDZ) (Myo18A). J Biochem (Tokyo) 2003; 133(4):405-13; PMID:12761286; http://dx.doi.org/10.1093/jb/mvg053
   PubMed Web of Science ®Google Scholar
• Yang C-H, Szeliga J, Jordan J, Faske S, Sever-Chroneos Z, Dorsett B, Christian RE, Settlage RE, Shabanowitz J, Hunt DF et al. Identification of the surfactant protein A receptor 210 as the unconventional myosin 18A. J Biol Chem 2005; 280(41):34447-57; PMID:16087679; http://dx.doi.org/10.1074/jbc.M505229200
   PubMed Web of Science ®Google Scholar
• Haagsman HP, Hawgood S, Sargeant T, Buckley D, White RT, Drickamer K, Benson BJ. The major lung surfactant protein, SP 28-36, is a calcium-dependent, carbohydrate-binding protein. J Biol Chem 1987; 262(29):13877-80; PMID:2820982
   PubMed Web of Science ®Google Scholar
• Mitsuhashi A, Goto H, Kuramoto T, Tabata S, Yukishige S, Abe S, Hanibuchi M, Kakiuchi S, Saijo A, Aono Y et al. Surfactant protein A suppresses lung cancer progression by regulating the polarization of tumor-associated macrophages. Am J Pathol 2013; 182(5):1843-53; PMID:23499372; http://dx.doi.org/10.1016/j.ajpath.2013.01.030
   PubMed Web of Science ®Google Scholar
• Cerwenka A, Lanier LL. Natural killer cells, viruses and cancer. Nat Rev Immunol 2001; 1(1):41-9; PMID:11905813; http://dx.doi.org/10.1038/35095564
   PubMed Web of Science ®Google Scholar
• McNeely TB, Coonrod JD. Aggregation and opsonization of type A but not type B Hemophilus influenzae by surfactant protein A. Am J Respir Cell Mol Biol 1994; 11(1):114-22; PMID:8018334; http://dx.doi.org/10.1165/ajrcmb.11.1.8018334
   PubMed Web of Science ®Google Scholar
• Pollok KE, Kim YJ, Hurtado J, Zhou Z, Kim KK, Kwon BS. 4-1BB T-cell antigen binds to mature B cells and macrophages, and costimulates anti-mu-primed splenic B cells. Eur J Immunol 1994; 24(2):367-74; PMID:8299685; http://dx.doi.org/10.1002/eji.1830240215
   PubMed Web of Science ®Google Scholar
• Zhao S, Zhang H, Xing Y, Natkunam Y. CD137 ligand is expressed in primary and secondary lymphoid follicles and in B-cell lymphomas: diagnostic and therapeutic implications. Am J Surg Pathol 2013; 37(2):250-8; PMID:23095505; http://dx.doi.org/10.1097/PAS.0b013e318268c6ea
   PubMed Web of Science ®Google Scholar
• Davis DM, Chiu I, Fassett M, Cohen GB, Mandelboim O, Strominger JL. The human natural killer cell immune synapse. Proc Natl Acad Sci U S A 1999; 96(26):15062-7; PMID:10611338; http://dx.doi.org/10.1073/pnas.96.26.15062
   PubMed Web of Science ®Google Scholar
• Rak GD, Mace EM, Banerjee PP, Svitkina T, Orange JS. Natural killer cell lytic granule secretion occurs through a pervasive actin network at the immune synapse. PLoS Biol 2011; 9(9):e1001151; PMID:21931536; http://dx.doi.org/10.1371/journal.pbio.1001151
   PubMedGoogle Scholar
• Brown ACN, Oddos S, Dobbie IM, Alakoskela J-M, Parton RM, Eissmann P, Neil MA, Dunsby C, French PM, Davis I et al. Remodelling of cortical actin where lytic granules dock at natural killer cell immune synapses revealed by super-resolution microscopy. PLoS Biol 2011; 9(9):e1001152; PMID:21931537; http://dx.doi.org/10.1371/journal.pbio.1001152
   PubMed Web of Science ®Google Scholar
• Hsu R-M, Tsai M-H, Hsieh Y-J, Lyu P-C, Yu J-S. Identification of MYO18A as a novel interacting partner of the PAK2/betaPIX/GIT1 complex and its potential function in modulating epithelial cell migration. Mol Biol Cell 2010; 21(2):287-301; PMID:19923322; http://dx.doi.org/10.1091/mbc.E09-03-0232
   PubMed Web of Science ®Google Scholar
• Burshtyn DN, Scharenberg AM, Wagtmann N, Rajagopalan S, Berrada K, Yi T, Kinet JP, Long EO. Recruitment of tyrosine phosphatase HCP by the killer cell inhibitor receptor. Immunity 1996; 4(1):77-85; PMID:8574854; http://dx.doi.org/10.1016/S1074-7613(00)80300-3
   PubMed Web of Science ®Google Scholar
• Stebbins CC, Watzl C, Billadeau DD, Leibson PJ, Burshtyn DN, Long EO. Vav1 dephosphorylation by the tyrosine phosphatase SHP-1 as a mechanism for inhibition of cellular cytotoxicity. Mol Cell Biol 2003; 23(17):6291-9; PMID:12917349; http://dx.doi.org/10.1128/MCB.23.17.6291-6299.2003
   PubMed Web of Science ®Google Scholar
• Mahmood S, Kanwar N, Tran J, Zhang M-L, Kung SKP. SHP-1 phosphatase is a critical regulator in preventing natural killer cell self-killing. PloS One 2012; 7(8):e44244; PMID:22952938; http://dx.doi.org/10.1371/journal.pone.0044244
   PubMedGoogle Scholar
• Purdy AK, Campbell KS. SHP-2 expression negatively regulates NK cell function. J Immunol 2009; 183(11):7234-43; PMID:19915046; http://dx.doi.org/10.4049/jimmunol.0900088
   PubMed Web of Science ®Google Scholar
• Dippold HC, Ng MM, Farber-Katz SE, Lee S-K, Kerr ML, Peterman MC, Sim R, Wiharto PA, Galbraith KA, Madhavarapu S et al. GOLPH3 bridges phosphatidylinositol-4- phosphate and actomyosin to stretch and shape the Golgi to promote budding. Cell 2009; 139(2):337-51; PMID:19837035; http://dx.doi.org/10.1016/j.cell.2009.07.052
   PubMed Web of Science ®Google Scholar
• Samten B, Townsend JC, Sever-Chroneos Z, Pasquinelli V, Barnes PF, Chroneos ZC. An antibody against the surfactant protein A (SP-A)-binding domain of the SP-A receptor inhibits T cell-mediated immune responses to Mycobacterium tuberculosis. J Leukoc Biol 2008; 84(1):115-23; PMID:18443188; http://dx.doi.org/10.1189/jlb.1207835
   PubMed Web of Science ®Google Scholar
• Mitra S, Beach C, Feng G-S, Plattner R. SHP-2 is a novel target of Abl kinases during cell proliferation. J Cell Sci 2008; 121(20):3335-46; PMID:18827006; http://dx.doi.org/10.1242/jcs.035691
   PubMed Web of Science ®Google Scholar
• MacGillivray M, Herrera-Abreu MT, Chow C-W, Shek C, Wang Q, Vachon E, Feng GS, Siminovitch KA, McCulloch CA, Downey GP. The protein tyrosine phosphatase SHP-2 regulates interleukin-1-induced ERK activation in fibroblasts. J Biol Chem 2003; 278(29):27190-8; PMID:12721296; http://dx.doi.org/10.1074/jbc.M213083200
   PubMed Web of Science ®Google Scholar
• Andzelm MM, Chen X, Krzewski K, Orange JS, Strominger JL. Myosin IIA is required for cytolytic granule exocytosis in human NK cells. J Exp Med 2007; 204(10):2285-91; PMID:17875677; http://dx.doi.org/10.1084/jem.20071143
   PubMed Web of Science ®Google Scholar
• Hsu R-M, Hsieh Y-J, Yang T-H, Chiang Y-C, Kan C-Y, Lin Y-T, Chen JT, Yu JS. Binding of the extreme carboxyl-terminus of PAK-interacting exchange factor β (βPIX) to myosin 18A (MYO18A) is required for epithelial cell migration. Biochim Biophys Acta 2014; 1843(11):2513-27; PMID:25014165; http://dx.doi.org/10.1016/j.bbamcr.2014.06.023
   PubMed Web of Science ®Google Scholar
• Furusawa T, Ikawa S, Yanai N, Obinata M. Isolation of a novel PDZ-containing myosin from hematopoietic supportive bone marrow stromal cell lines. Biochem Biophys Res Commun 2000; 270(1):67-75; PMID:10733906; http://dx.doi.org/10.1006/bbrc.2000.2377
   PubMed Web of Science ®Google Scholar
• Nakano T, Tani M, Nishioka M, Kohno T, Otsuka A, Ohwada S, Yokota J. Genetic and epigenetic alterations of the candidate tumor-suppressor gene MYO18B, on chromosome arm 22q, in colorectal cancer. Genes Chromosomes Cancer 2005; 43(2):162-71; PMID:15751041; http://dx.doi.org/10.1002/gcc.20180
   PubMed Web of Science ®Google Scholar
• Nishioka M, Kohno T, Tani M, Yanaihara N, Tomizawa Y, Otsuka A, Sasaki S, Kobayashi K, Niki T, Maeshima A et al. MYO18B, a candidate tumor suppressor gene at chromosome 22q12.1, deleted, mutated, and methylated in human lung cancer. Proc Natl Acad Sci U S A 2002; 99(19):12269-74; PMID:12209013; http://dx.doi.org/10.1073/pnas.192445899
   PubMed Web of Science ®Google Scholar
• Taft MH, Behrmann E, Munske-Weidemann L-C, Thiel C, Raunser S, Manstein DJ. Functional characterization of human myosin-18A and its interaction with F-actin and GOLPH3. J Biol Chem 2013; 288(42):30029-41; PMID:23990465; http://dx.doi.org/10.1074/jbc.M113.497180
   PubMed Web of Science ®Google Scholar
• Farber-Katz SE, Dippold HC, Buschman MD, Peterman MC, Xing M, Noakes CJ, Tat J, Ng MM, Rahajeng J, Cowan DM et al. DNA damage triggers Golgi dispersal via DNA-PK and GOLPH3. Cell 2014; 156(3):413-27; PMID:24485452; http://dx.doi.org/10.1016/j.cell.2013.12.023
   PubMed Web of Science ®Google Scholar
• Kuroki Y, Tsutahara S, Shijubo N, Takahashi H, Shiratori M, Hattori A, Honda Y, Abe S, Akino T. Elevated levels of lung surfactant protein A in sera from patients with idiopathic pulmonary fibrosis and pulmonary alveolar proteinosis. Am Rev Respir Dis 1993; 147(3):723-9; PMID:8442609; http://dx.doi.org/10.1164/ajrccm/147.3.723
   PubMed Web of Science ®Google Scholar
• Rubio S, Lacaze-Masmonteil T, Chailley-Heu B, Kahn A, Bourbon JR, Ducroc R. Pulmonary surfactant protein A (SP-A) is expressed by epithelial cells of small and large intestine. J Biol Chem 1995; 270(20):12162-9; PMID:7744866; http://dx.doi.org/10.1074/jbc.270.20.12162
   PubMed Web of Science ®Google Scholar
• Aiad HAS, El-Farargy SM, Soliman MM, El-Wahed Gaber MA, El-Aziz Othman SA. Immunohistochemical staining of surfactant proteins A and B in skin of psoriatic patients before and after narrow-band UVB phototherapy. Am J Clin Dermatol 2012; 13(5):341-8; PMID:22621659; http://dx.doi.org/10.2165/11630720-000000000-00000
   PubMed Web of Science ®Google Scholar
• Cunningham D, Humblet Y, Siena S, Khayat D, Bleiberg H, Santoro A, Bets D, Mueser M, Harstrick A, Verslype C et al. Cetuximab monotherapy and cetuximab plus irinotecan in irinotecan-refractory metastatic colorectal cancer. N Engl J Med 2004; 351(4):337-45; PMID:15269313; http://dx.doi.org/10.1056/NEJMoa033025
   PubMed Web of Science ®Google Scholar